GT
JNJ icon

Glenmede Trust’s Johnson & Johnson JNJ Stock Holding History

Glenmede Trust’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.78M Buy
+40,000
New +$9.32M 0.05% 335
2022
Q3 		– Sell
-1,201
Closed -$3K – 1303
2022
Q2 		$3K Buy
+1,201
New +$214K ﹤0.01% 1274
2021
Q1 		– Sell
-542
Closed -$1K – 1229
2020
Q4 		$1K Buy
+542
New +$80K ﹤0.01% 1189

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Glenmede Trust's JNJ Position: Q1 2026 in Review

Glenmede Trust reduced its Johnson & Johnson (JNJ) stake by 1.5% in Q1 2026, selling an estimated $4.81M and leaving 1,382,668 shares worth $338M. The position accounts for 1.66% of the portfolio, ranked #7.

Glenmede Trust first reported a position in JNJ in Q2 2013 and has held it in 50 quarters since. The position peaked at $1.24B in Q1 2018. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Glenmede Trust held 1,382,668 shares of Johnson & Johnson worth $338M as of Q1 2026.
  • Glenmede Trust sold 20,653 Johnson & Johnson shares in Q1 2026, an estimated $4.81M.
  • Johnson & Johnson made up 1.66% of Glenmede Trust's portfolio in Q1 2026, its #7 holding.
  • Glenmede Trust first reported a position in Johnson & Johnson in Q2 2013 and has held it in 50 quarters since.
  • Glenmede Trust's Johnson & Johnson position peaked at $1.24B in Q1 2018.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.